Takeaways: Health Canada’s approval of Fujirebio’s Lumipulse G NfL Blood and pTau217 Plasma assays brings two high‑demand, blood‑based neurology tests into the Canadian marke...
Browsing Tag: Alzheimer’s disease biomarkers
Takeaways: Health Canada’s approval of Fujirebio’s Lumipulse G NfL Blood and pTau217 Plasma assays brings two high‑demand, blood‑based neurology tests into the Canadian marke...